Indian Drug Makers Offer Deal To Avoid Increased Price Controls
This article was originally published in PharmAsia News
Executive Summary
Drug makers in India are offering to sell some of their more important products at half of their maximum retail price to stave off greater price controls. But their offer is conditioned on the Indian government promising not to expand its cost-based price control policy. In addition to the half-off offer on some drugs, companies are offering to contribute a quarter of a percent of total profits to the government. An acceptance by the government would be considered a big change in the way India deals with the increasing cost of health care. (Click here for more